WST

West Pharmaceutical Services
D

WST

Arincen83/100B

West Pharmaceutical Services balance sheet 1985–2026

West Pharmaceutical Services had 464.10M USD in cash and short-term investments on 30 September 2026, against total debt of 305.00M USD: net cash of 159.10M USD.

Total assets Total liabilities Shareholders' equity

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
Latest
Q3 FY2026
FY2025
31 Dec 2025
FY2024
31 Dec 2024
FY2023
31 Dec 2023
FY2022
31 Dec 2022
FY2021
31 Dec 2021
FY2020
31 Dec 2020
FY2019
31 Dec 2019
FY2018
31 Dec 2018
FY2017
31 Dec 2017
FY2016
31 Dec 2016
Cash and equivalents
464.10M791.30M484.60M853.90M894.30M762.60M615.50M439.10M337.40M235.90M203.00M
Short-term investments
0.000.000.000.000.000.000.000.000.000.000.00
464.10M791.30M484.60M853.90M894.30M762.60M615.50M439.10M337.40M235.90M203.00M
Cash growth
-26.16%+63.29%-43.25%-4.52%+17.27%+23.90%+40.17%+30.14%+43.03%+16.21%-26.07%
Receivables
748.20M574.40M552.50M512.00M507.40M489.00M385.30M319.30M288.20M253.20M200.50M
Inventory
464.70M443.90M377.00M434.70M414.80M378.40M321.30M235.70M214.50M215.20M199.30M
Other current assets
139.50M168.60M124.00M135.80M103.00M112.00M51.60M64.60M54.30M39.20M39.10M
Total current assets
1.82B1.98B1.54B1.94B1.92B1.74B1.37B1.06B894.40M743.50M641.90M
Property, plant and equipment
1.77B1.84B1.69B1.51B1.26B1.13B1.01B909.40M822.00M855.00M778.30M
Long-term investments
215.80M212.30M202.10M210.00M204.90M207.70M214.70M192.70M91.20M85.80M82.70M
Goodwill and intangibles
114.90M117.70M116.90M123.60M125.70M132.90M141.60M137.60M126.20M129.40M126.30M
Goodwill
108.70M110.00M106.10M108.50M107.30M109.90M111.10M107.80M105.80M107.70M103.00M
Intangible assets
6.20M7.70M10.80M15.10M18.40M23.00M30.50M29.80M20.40M21.70M23.30M
Other non-current assets
82.90M80.10M74.30M21.30M38.40M55.90M36.30M29.00M20.50M23.40M21.30M
Total assets
4.06B4.27B3.64B3.83B3.62B3.31B2.79B2.34B1.59B1.86B1.72B
Accounts payable
249.40M253.70M239.30M242.40M215.40M232.20M213.10M156.80M130.40M138.10M122.00M
Deferred revenue
0.000.0049.60M41.70M57.30M48.70M51.00M27.50M25.50M18.40M13.20M
Short-term debt
0.0022.70M18.80M134.00M2.20M44.20M2.30M2.30M100.00K0.002.40M
Other current liabilities
212.50M214.50M100.50M54.20M54.00M45.10M49.90M28.80M22.60M22.70M17.50M
Total current liabilities
644.30M654.90M550.40M671.80M519.00M594.10M503.40M341.60M283.70M279.50M241.00M
Long-term debt
202.90M298.40M202.60M72.80M206.70M208.80M252.90M255.00M196.00M197.00M226.20M
Other non-current liabilities
139.70M22.10M103.70M106.70M98.90M107.60M112.20M93.70M89.80M96.00M122.80M
Lease obligations, current
19.50M0.000.0017.70M16.00M9.30M10.10M9.60M0.000.000.00
Lease obligations, long-term
82.60M95.60M83.90M84.50M93.00M63.00M60.40M62.40M0.000.000.00
Total liabilities
1.09B1.09B961.10M948.50M931.90M978.40M939.30M768.20M582.60M582.90M599.20M
Common stock and paid-in capital
18.80M18.80M18.80M18.80M18.80M18.80M18.80M18.80M18.80M18.80M18.40M
Retained earnings
4.82B4.37B3.96B3.52B2.99B2.46B1.85B1.55B1.35B1.18B1.07B
Accumulated other comprehensive income
-137.00M-105.50M-258.10M-143.80M-183.00M-159.60M-110.60M-149.60M-154.20M-117.30M-186.80M
Shareholders' equity
2.97B3.18B2.68B2.88B2.68B2.34B1.85B1.57B1.40B1.28B1.12B
Minority interest
0.000.000.000.000.000.000.000.000.000.000.00
305.00M321.10M305.30M309.00M317.90M325.30M325.70M329.30M196.10M197.00M228.60M
Net cash
159.10M470.20M179.30M544.90M576.40M437.30M289.80M109.80M141.30M38.90M-25.60M
Working capital
1.17B1.32B987.70M1.26B1.40B1.15B870.30M717.10M610.70M464.00M400.90M
Book value per share
41.9243.6936.3938.2635.4230.6124.4720.8618.5216.8914.90
Tangible book value
2.85B3.06B2.57B2.76B2.56B2.20B1.71B1.44B1.27B1.15B991.20M
Tangible book value per share
40.3042.0734.8136.6233.7628.8722.6019.0416.8415.1813.22
Current ratio
2.823.022.792.883.702.932.733.103.152.662.66
Debt to equity
0.100.100.110.110.120.140.180.210.140.150.20

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

Figures underlined with dots are from the company's SEC filings, where our data provider's differ.

Common questions about West Pharmaceutical Services's cash and debt

Source: Financial Modeling Prep